Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Satellos Bioscience Inc (MSCLF)

Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc. Newsfile - Fri Dec 20, 4:14PM CST

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton) announces that, today, it acquired 1,692,250 common shares (Shares) of Satellos Bioscience Inc. (Corporation)...

MSCLF : 0.6200 (unch)
MSCL.TO : 0.88 (+1.15%)
Satellos to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023 Newsfile - Wed Sep 20, 2023

Toronto, Ontario--(Newsfile Corp. - September 20, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic...

MSCLF : 0.6200 (unch)
MSCL.VN : 0.560 (+1.82%)
Satellos Bioscience Enters Into an Agreement with ICP Securities Inc. to Provide Market Making Services Newsfile - Fri Sep 8, 2023

Toronto, Ontario--(Newsfile Corp. - September 7, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic...

MSCLF : 0.6200 (unch)
MSCL.VN : 0.560 (+1.82%)
Satellos Expands Leadership Team with New CFO Appointment Newsfile - Tue Sep 5, 2023

Elizabeth Williams, CPA, CA, joins as CFO, bringing extensive expertise leading corporate finance and strategy for public biotech companies listed on Nasdaq and TSX.Current CFO, Warren Whitehead, CPA,...

MSCLF : 0.6200 (unch)
MSCL.VN : 0.560 (+1.82%)
Satellos Bioscience Announces Q2 2023 Financial Results and Operational Highlights Newsfile - Tue Aug 29, 2023

$48.7 million in cash and cash equivalents at June 30, 2023, providing expected runway to advance Company's development candidate ("DC") through Phase I clinical development in healthy human volunteers...

MSCLF : 0.6200 (unch)
MSCL.VN : 0.560 (+1.82%)
Satellos Bioscience Receives Orphan Drug Designation from the U.S. FDA for SAT-3153, a First-in-Class Small Molecule Therapeutic for Duchenne Muscular Dystrophy Newsfile - Wed Aug 2, 2023

Company also recently received Rare Pediatric Disease Designation from the FDA for SAT-3153 for the treatment of pediatric patients with DuchenneToronto, Ontario--(Newsfile Corp. - August 2, 2023) - Satellos...

MSCLF : 0.6200 (unch)
MSCL.VN : 0.560 (+1.82%)
Satellos Bioscience Announces Results from Its Annual General Meeting of Shareholders and Adoption of Amendments to Stock Option Plan Newsfile - Fri Jun 30, 2023

Toronto, Ontario--(Newsfile Corp. - June 30, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the...

MSCLF : 0.6200 (unch)
MSCL.VN : 0.560 (+1.82%)
Satellos Bioscience Announces Appointment of Chief Medical Officer Newsfile - Wed Jun 7, 2023

Dr. Alan K. Jacobs joins Satellos as CMO on June 7th, 2023Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine...

MSCLF : 0.6200 (unch)
MSCL.VN : 0.560 (+1.82%)
Satellos Bioscience Announces Grant of Stock Options Newsfile - Thu Jun 1, 2023

Toronto, Ontario--(Newsfile Corp. - June 1, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the...

MSCLF : 0.6200 (unch)
MSCL.VN : 0.560 (+1.82%)
Satellos Bioscience Announces 2023 Q1 Financial Results and Operational Highlights Newsfile - Tue May 30, 2023

- $55 million equity financing closed- Resourced to advance lead drug candidate into clinical trialsToronto, Ontario--(Newsfile Corp. - May 30, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos"...

MSCLF : 0.6200 (unch)
MSCL.VN : 0.560 (+1.82%)

Barchart Exclusives

Bank of America Says to Crash Proof Your Portfolio With These 3 ‘Magnificent 7’ Stocks Barchart - Fri Dec 27, 6:30AM CST
Anticipating a correction, BofA analysts see these tech giants as safe bets. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot